Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;69(11):3026-3034.
doi: 10.4103/ijo.IJO_1525_21.

Asymmetric diabetic retinopathy

Rajvardhan Azad  1 , Sony Sinha  2 , Prateek Nishant  3
Affiliations
Review

Asymmetric diabetic retinopathy

Rajvardhan Azad et al. Indian J Ophthalmol. 2021 Nov.

Abstract

Increasing prevalence of diabetes mellitus warrants recognition of factors related to asymmetric diabetic retinopathy (DR). This thematic synthesis based on an iterative literature review conducted in Medline and Google Scholar pertaining to diabetes with coexistent asymmetry of retinopathy included 45 original articles, 21 case reports and series, and 18 review articles from 1965 to 2020. Asymmetric DR is defined as proliferative DR (PDR) in one eye and nonproliferative, preproliferative, background, or no DR in the other eye lasting for at least 2 years. It is observed in 5%-10% of patients with PDR. Associated factors can be divided into (i) vascular: carotid obstructive disease, ocular ischemic syndrome, and retinal vascular diseases; (ii) Inflammatory: uveitis, endophthalmitis, and Fuchs' heterochromic cyclitis; (iii) degenerative: posterior vitreous detachment, high myopia and anisometropia, uveal coloboma, retinal detachment, retinitis pigmentosa, and chorioretinal atrophy and scarring; (iv) cataract surgery and vitrectomy; and (v) miscellaneous: elevated intraocular pressure, glaucoma, amblyopia, retinal detachment, and optic atrophy. The gamut of diagnostic modalities for asymmetric DR includes thorough ocular examination, slit-lamp biomicroscopy, fundus photography, fundus fluorescein angiography, optical coherence tomography, and newer modalities such as ultra-widefield fluorescein angiography and optical coherence tomography angiography, along with a complete systemic evaluation and carotid Doppler studies. The differential diagnosis includes other causes of retinal neovascularization that may present in an asymmetric manner, such as sickle cell retinopathy, retinal vein occlusions, and featureless retina. This review discusses in detail the aforementioned considerations and draws a comprehensive picture of asymmetric DR in order to sensitize ophthalmologists to this important condition.

Keywords: Carotid artery disease; diabetes mellitus; neovascularization; ocular ischemic syndrome.

PubMed Disclaimer

Conflict of interest statement

None

References

    1. Valone JA, McMeel JW, Franks EP. Unilateral proliferative diabetic retinopathy. I. Initial findings. Arch Ophthalmol. 1981;99:1357–61. - PubMed
    1. Valone JA, McMeel JW, Franks EP. Unilateral proliferative diabetic retinopathy. II. Clinical course. Arch Ophthalmol. 1981;99:1362–6. - PubMed
    1. Browning DJ, Flynn HW, Blankenship GW. Asymmetric retinopathy in patients with diabetes mellitus. Am J Ophthalmol. 1988;105:584–9. - PubMed
    1. Duker JS, Brown GC, Bosley TM, Colt CA, Reber R. Asymmetric proliferative diabetic retinopathy and carotid artery disease. Ophthalmology. 1990;97:869–74. - PubMed
    1. Iino K, Yoshinari M, Kaku K, Yamamoto M, Sato Y, Kodama T, et al. Prospective study of asymmetric retinopathy as a predictor of brain infarction in diabetes mellitus. Diabetes Care. 1993;16:1405–6. - PubMed